Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Betteridge

Showing results (281-290 of 297) with videos related to

Pageof 30
Sort By:
Atherosclerosis|April 2, 2010
All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry studyH A W Neil, J Cooper, D J Betteridge, et al.
Atherosclerosis|March 1, 1995
Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistanceK C Tan, M B Cooper, K L Ling, et al.
BMJ (Clinical Research Ed.)|May 23, 1992
Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramineD J Betteridge, D Bhatnager, R F Bing, et al.
Diabetologia|July 20, 2007
Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetesK C B Tan, W S Chow, A W K Tso, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2002
Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetesH M Colhoun, M J Thomason, M I Mackness, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetesM J Thomason, H M Colhoun, S J Livingstone, et al.
Diabetologia|February 1, 2007
Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)M Raikou, A McGuire, H M Colhoun, et al.
Diabetes Research (Edinburgh, Scotland)|January 1, 1987
Glycaemic control in diabetic patients transferred from therapy with animal insulins to human crystalline zinc insulin of recombinant DNA origin: a multicentre studyJ M Leiper, R R Campbell, L D Curtis, et al.
Postgraduate Medical Journal|May 1, 1993
Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia AssociationD J Betteridge, P M Dodson, P N Durrington, et al.
The American Journal of Medicine|June 6, 1994
Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemiaD J Betteridge, P N Durrington, G J Fairhurst, et al.
Pageof 30

Showing results (281-290 of 297) with videos related to

Sort By:
Pageof 30
Atherosclerosis|April 2, 2010
All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry studyH A W Neil, J Cooper, D J Betteridge, et al.
Atherosclerosis|March 1, 1995
Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistanceK C Tan, M B Cooper, K L Ling, et al.
BMJ (Clinical Research Ed.)|May 23, 1992
Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramineD J Betteridge, D Bhatnager, R F Bing, et al.
Diabetologia|July 20, 2007
Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetesK C B Tan, W S Chow, A W K Tso, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2002
Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetesH M Colhoun, M J Thomason, M I Mackness, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetesM J Thomason, H M Colhoun, S J Livingstone, et al.
Diabetologia|February 1, 2007
Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)M Raikou, A McGuire, H M Colhoun, et al.
Diabetes Research (Edinburgh, Scotland)|January 1, 1987
Glycaemic control in diabetic patients transferred from therapy with animal insulins to human crystalline zinc insulin of recombinant DNA origin: a multicentre studyJ M Leiper, R R Campbell, L D Curtis, et al.
Postgraduate Medical Journal|May 1, 1993
Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia AssociationD J Betteridge, P M Dodson, P N Durrington, et al.
The American Journal of Medicine|June 6, 1994
Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemiaD J Betteridge, P N Durrington, G J Fairhurst, et al.
Pageof 30